|
WO1991014438A1
(en)
|
1990-03-20 |
1991-10-03 |
The Trustees Of Columbia University In The City Of New York |
Chimeric antibodies with receptor binding ligands in place of their constant region
|
|
AU2752892A
(en)
|
1991-09-26 |
1993-04-27 |
Oklahoma Medical Research Foundation |
Fusion proteins targeted to lysosomes, for the treatment of aids
|
|
GB9323429D0
(en)
|
1993-11-12 |
1994-01-05 |
Wellcome Found |
Therapy
|
|
DK129293D0
(da)
|
1993-11-16 |
1993-11-16 |
Carlsberg Lab |
Carbonhydratholdige forbindelser, der kan binde sig til carbonhydratbindende receptorer
|
|
US7422902B1
(en)
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
|
US20020168761A1
(en)
|
2000-01-24 |
2002-11-14 |
Gour Barbara J. |
Peptidomimetic modulators of cell adhesion
|
|
US6083725A
(en)
|
1996-09-13 |
2000-07-04 |
Transkaryotic Therapies, Inc. |
Tranfected human cells expressing human α-galactosidase A protein
|
|
AU2662999A
(en)
|
1998-02-09 |
1999-08-23 |
Genzyme Corporation |
Nucleic acid delivery vehicles
|
|
US6093382A
(en)
|
1998-05-16 |
2000-07-25 |
Bracco Research Usa Inc. |
Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
|
|
AU770340B2
(en)
|
1998-10-08 |
2004-02-19 |
Biorion Technologies B.V. |
Peptide-based carrier devices for stellate cells
|
|
US6426208B1
(en)
|
1999-11-12 |
2002-07-30 |
Harbor-Ucla Research And Education Institute |
Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
|
|
EP1242824A2
(en)
|
1999-12-30 |
2002-09-25 |
7TM Pharma |
Screening using biological target molecules with metal-ion binding sites
|
|
US20040009907A1
(en)
|
2001-02-26 |
2004-01-15 |
Alsobrook John P. |
Proteins and nucleic acids encoding same
|
|
EP1284752A4
(en)
|
2000-04-26 |
2004-08-18 |
Elusys Therapeutics Inc |
BISPECIFIC MOLECULES AND USES THEREOF
|
|
DE10138935B4
(de)
*
|
2000-08-11 |
2007-08-02 |
Kotobuki Pharmaceutical Co., Ltd, , Hanishina |
Synthetische Verbindungen vom Nicht-Mucintyp oder ihre mit einem Träger konjugierten Verbindungen, unter deren Verwendung hergestellte monoclonale Antikörper, diese umfassende Antitumormittel Immunstimulantien und Mittel gegen das humane Immundefizienzvirus
|
|
NZ524980A
(en)
|
2000-09-01 |
2005-10-28 |
Biogen Idec Inc |
Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications
|
|
EP1385538B1
(en)
|
2001-04-05 |
2013-01-30 |
The Johns Hopkins University |
Chimeric Vaccines comprising the lumenal domain of LAMP-1 or LAMP-2
|
|
US7560424B2
(en)
|
2001-04-30 |
2009-07-14 |
Zystor Therapeutics, Inc. |
Targeted therapeutic proteins
|
|
MXPA05000511A
(es)
|
2001-07-12 |
2005-09-30 |
Jefferson Foote |
Anticuepros super humanizados.
|
|
US20030049203A1
(en)
|
2001-08-31 |
2003-03-13 |
Elmaleh David R. |
Targeted nucleic acid constructs and uses related thereto
|
|
ES2411007T3
(es)
|
2001-10-10 |
2013-07-04 |
Novo Nordisk A/S |
Remodelación y glicoconjugación de péptidos
|
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
|
JP4801348B2
(ja)
|
2002-05-06 |
2011-10-26 |
エンドサイト，インコーポレイテッド |
ビタミンを標的とした造影剤
|
|
US20050191309A1
(en)
|
2002-05-06 |
2005-09-01 |
Kakkis Emil D. |
Induction of antigen specific immunologic tolerance
|
|
US7485314B2
(en)
|
2002-05-06 |
2009-02-03 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Induction of antigen specific immunologic tolerance
|
|
AU2002950217A0
(en)
|
2002-07-16 |
2002-09-12 |
Prana Biotechnology Limited |
8- Hydroxy Quinoline Derivatives
|
|
ES2330004T3
(es)
|
2003-05-20 |
2009-12-03 |
Pharmaxis Pty Ltd. |
Compuestos de manosa-6-fosfonato para el tratamiento de enfermedades inflamatorias.
|
|
US7442372B2
(en)
|
2003-08-29 |
2008-10-28 |
Biomarin Pharmaceutical Inc. |
Delivery of therapeutic compounds to the brain and other tissues
|
|
US8889127B2
(en)
|
2004-07-01 |
2014-11-18 |
Icahn School Of Medicine At Mount Sinai |
Targeted protein replacement for the treatment of lysosomal storage disorders
|
|
DK1791565T3
(en)
|
2004-09-23 |
2016-08-01 |
Genentech Inc |
Cysteingensplejsede antibodies and conjugates
|
|
GB0423405D0
(en)
|
2004-10-21 |
2004-11-24 |
Novartis Ag |
Organic compounds
|
|
EP1904183B1
(en)
|
2005-07-05 |
2014-10-15 |
Purdue Research Foundation |
Pharmaceutical composition for the treatment of osteoarthritis
|
|
EP1745802A1
(en)
|
2005-07-20 |
2007-01-24 |
Kreatech Biotechnology B.V. |
Method of conjugating therapeutic compounds to cell targeting moieties via metal complexes
|
|
WO2008020827A2
(en)
|
2005-08-01 |
2008-02-21 |
Biogen Idec Ma Inc. |
Altered polypeptides, immunoconjugates thereof, and methods related thereto
|
|
US20070104648A1
(en)
|
2005-11-09 |
2007-05-10 |
Glyconix Corporation |
Compositions, methods of preparing amino acids, and nuclear magnetic resonance spectroscopy
|
|
AU2007234698B2
(en)
|
2006-04-07 |
2013-08-01 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions related to adenoassociated virus-phage particles
|
|
US20080057072A1
(en)
|
2006-08-31 |
2008-03-06 |
Alcon Manufacturing, Ltd. |
Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders
|
|
RU2500685C2
(ru)
|
2006-11-10 |
2013-12-10 |
Кара Терапеутикс, Инк |
Синтетические пептидные амиды
|
|
WO2008089339A2
(en)
|
2007-01-18 |
2008-07-24 |
Genzyme Corporation |
Oligosaccharide conjugates for cellular targeting
|
|
CA2690627C
(en)
|
2007-06-15 |
2014-12-02 |
Genelux Corporation |
Microorganisms for imaging and/or treatment of tumors
|
|
JP5366940B2
(ja)
|
2008-05-08 |
2013-12-11 |
日本化薬株式会社 |
葉酸若しくは葉酸誘導体の高分子結合体
|
|
ES3029483T3
(en)
|
2008-09-17 |
2025-06-24 |
Endocyte Inc |
Folate receptor binding conjugates of antifolates
|
|
GB0817891D0
(en)
|
2008-09-30 |
2008-11-05 |
Medical Res Council |
Antibodies against il-25
|
|
CN102369023A
(zh)
|
2008-12-16 |
2012-03-07 |
建新公司 |
寡糖-蛋白缀合物
|
|
US20110275576A1
(en)
*
|
2009-01-06 |
2011-11-10 |
Utah State University |
Carbohydrate-Cyclopamine Conjugates as Anticancer Agents
|
|
KR101722961B1
(ko)
|
2009-02-11 |
2017-04-04 |
알부메딕스 에이/에스 |
알부민 변이체 및 접합체
|
|
CA2748889A1
(en)
|
2009-03-18 |
2010-09-23 |
Armagen Technologies, Inc. |
Compositions and methods for blood-brain barrier delivery of igg-decoy receptor fusion proteins
|
|
US8557783B2
(en)
|
2009-04-28 |
2013-10-15 |
Pharmaxis Pty Limited |
Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders
|
|
US8962573B2
(en)
|
2009-07-03 |
2015-02-24 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Compounds targeting the cation-independent mannose 6-phosphate receptor
|
|
EP2480235A4
(en)
|
2009-09-24 |
2013-05-08 |
Univ Louisville Res Found |
NEW IODO-PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ILLNESSES AND SUFFERING IN CONNECTION WITH THE MACROPHAGE MIGRATION-INHIBITING FACTOR
|
|
FR2952372B1
(fr)
|
2009-11-10 |
2012-03-23 |
Centre Nat Rech Scient |
Nouveaux derives de mannopyranoside ayant une activite anticancereuse
|
|
EP2343081A1
(en)
|
2009-12-31 |
2011-07-13 |
Rijksuniversiteit Groningen |
Interferon analogs
|
|
TWI622402B
(zh)
|
2010-02-24 |
2018-05-01 |
免疫遺傳股份有限公司 |
葉酸受體１抗體類和免疫共軛物類及彼等之用途
|
|
FR2960153B1
(fr)
|
2010-05-20 |
2012-08-17 |
Centre Nat Rech Scient |
Nouveaux bras autoreactifs et prodrogues les comprenant
|
|
RU2012157167A
(ru)
|
2010-07-12 |
2014-08-20 |
КовЭкс Текнолоджиз Айэлэнд Лимитед |
Полифункциональные антительные конъюгаты
|
|
US20120121592A1
(en)
|
2010-10-13 |
2012-05-17 |
Baylor Research Institute |
Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells
|
|
HRP20180291T1
(hr)
|
2011-05-27 |
2018-03-23 |
Amicus Therapeutics, Inc. |
Postupci za sparivanje ciljajućeg peptida na rekombinantne lizosomalne enzime za poboljšano liječenje lizosomskih bolesti nakupljanja
|
|
EP2825553B1
(en)
|
2012-03-14 |
2018-07-25 |
Regeneron Pharmaceuticals, Inc. |
Multispecific antigen-binding molecules and uses thereof
|
|
CA3140358A1
(en)
|
2012-07-31 |
2014-02-06 |
Bioasis Technologies, Inc. |
Dephosphorylated lysosomal storage disease proteins and methods of use thereof
|
|
WO2014082080A2
(en)
|
2012-11-26 |
2014-05-30 |
Callidus Biopharma, Inc. |
Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases
|
|
WO2014089209A2
(en)
|
2012-12-04 |
2014-06-12 |
Abbvie, Inc. |
Blood-brain barrier (bbb) penetrating dual specific binding proteins
|
|
AU2014218854B2
(en)
|
2013-02-20 |
2019-01-24 |
Valerion Therapeutics, Llc |
Methods and compositions for treatment of Pompe disease
|
|
ES2824026T3
(es)
|
2013-05-03 |
2021-05-11 |
Univ Yale |
Compuestos miméticos de anticuerpos sintéticos (SyAM) dirigidos al cáncer, especialmente cáncer de próstata
|
|
US9545451B2
(en)
|
2013-08-21 |
2017-01-17 |
Regeneron Pharmaceuticals, Inc. |
Anti-PRLR antibodies and methods for killing PRLR-expressing cells
|
|
TWI641620B
(zh)
|
2013-08-21 |
2018-11-21 |
再生元醫藥公司 |
抗－ｐｒｌｒ抗體及其用途
|
|
WO2015042447A1
(en)
*
|
2013-09-20 |
2015-03-26 |
Isis Pharmaceuticals, Inc. |
Targeted therapeutic nucleosides and their use
|
|
EP3610884B1
(en)
|
2013-11-06 |
2021-08-18 |
Merck Sharp & Dohme Corp. |
Peptide containing conjugates for dual molecular delivery of oligonucleotides
|
|
SG11201606761RA
(en)
*
|
2014-02-21 |
2016-09-29 |
Ecole Polytecnique Federale De Lausanne Epfl Epfl Tto |
Glycotargeting therapeutics
|
|
WO2015143091A1
(en)
|
2014-03-19 |
2015-09-24 |
Genzyme Corporation |
Site-specific glycoengineering of targeting moieties
|
|
PL3145934T3
(pl)
|
2014-05-19 |
2021-08-16 |
Pfizer Inc. |
Podstawione związki 6,8-dioksabicyklo[3.2.1]oktano-2,3-diolu jako środki kierujące do ASGPR
|
|
WO2015191934A2
(en)
|
2014-06-11 |
2015-12-17 |
Abbvie Inc. |
Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases
|
|
EP3185889B1
(en)
|
2014-08-11 |
2020-07-15 |
Shire Human Genetic Therapies, Inc. |
Mannose-6-phosphate bearing peptides fused to lysosomal enzymes
|
|
US20170290806A1
(en)
|
2014-09-08 |
2017-10-12 |
Temple University-Of The Commonwealth System Of Higher Education |
PCSK9 Inhibitors and Methods of Use Thereof
|
|
CA3205824A1
(en)
|
2014-10-09 |
2016-04-14 |
Genzyme Corporation |
Glycoengineered antibody drug conjugates
|
|
US20160166679A1
(en)
|
2014-12-12 |
2016-06-16 |
Purdue Research Foundation |
Method of treatment using folate conjugates and tyrosine kinase inhibitors
|
|
IL296285A
(en)
|
2015-07-06 |
2022-11-01 |
Regeneron Pharma |
Multispecific antigen-binding molecules and uses thereof
|
|
JP7007261B2
(ja)
|
2015-08-20 |
2022-01-24 |
アルブミディクス リミティド |
アルブミン変異体及びコンジュゲート
|
|
FR3041345B1
(fr)
|
2015-09-18 |
2019-06-14 |
Nanomedsyn |
Composes polysaccharides multi-fonctionnalises et leur utilisation pour cibler le recepteur du mannose 6-phosphate cation-independant
|
|
CA3289997A1
(en)
|
2015-09-20 |
2026-03-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Monoclonal Antibodies Specific for Fibroblast Growth Factor Receptor 4 (FGFR4) and Methods of Their Use
|
|
EP3356415B1
(en)
|
2015-09-29 |
2024-05-01 |
Amgen Inc. |
Asgr inhibitors for reduzing cholesterol levels
|
|
EP3384034B1
(en)
|
2015-12-02 |
2020-07-08 |
The Board of Trustees of the Leland Stanford Junior University |
Novel recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
|
|
DK3386534T3
(da)
|
2015-12-08 |
2020-11-30 |
Regeneron Pharma |
Sammensætninger og fremgangsmåder til internalisering af enzymer
|
|
KR20260018979A
(ko)
|
2016-02-05 |
2026-02-09 |
젠맵 에이/에스 |
개선된 내재화 특징을 갖는 다중특이적 항원-결합 분자
|
|
EP3411484B1
(en)
|
2016-02-05 |
2023-10-04 |
Emory University |
Injection of single-stranded or self-complementary adeno-associated virus 9 into the cerebrospinal fluid
|
|
WO2017212019A1
(en)
|
2016-06-09 |
2017-12-14 |
Centre National De La Recherche Scientifique (Cnrs) |
Raav with chemically modified capsid
|
|
KR102085798B1
(ko)
|
2016-12-28 |
2020-03-06 |
주식회사 인투셀 |
베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물
|
|
DK3635009T3
(da)
|
2017-06-07 |
2026-03-30 |
Regeneron Pharma |
Sammensætninger og fremgangsmåder til internalisering af enzymer
|
|
EP3773727A4
(en)
|
2018-04-09 |
2022-05-04 |
Yale University |
BIFUNCTIONAL SMALL MOLECULES TO TARGETING THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS
|
|
WO2019199621A1
(en)
|
2018-04-09 |
2019-10-17 |
Yale University |
Bi-functional molecules to degrade circulating proteins
|
|
JP2022506517A
(ja)
*
|
2018-11-02 |
2022-01-17 |
アルブータス・バイオファーマー・コーポレイション |
標的指向化二価結合体
|
|
AU2019404061A1
(en)
|
2018-12-19 |
2021-07-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Bifunctional molecules for lysosomal targeting and related compositions and methods
|
|
GB2589049C
(en)
|
2019-04-11 |
2024-02-21 |
argenx BV |
Anti-IgE antibodies
|
|
GB201908108D0
(en)
|
2019-06-06 |
2019-07-24 |
King S College London |
Product
|
|
EP3986936A4
(en)
|
2019-06-21 |
2023-03-15 |
Single Cell Technology, Inc. |
ANTI-TIGIT ANTIBODIES
|
|
EP3997214B1
(en)
|
2019-07-11 |
2023-08-02 |
Centre National de la Recherche Scientifique |
Chemically-modified adeno-associated virus
|
|
EP4041262A4
(en)
|
2019-10-10 |
2024-03-13 |
Yale University |
Targeted bifunctional degraders
|
|
KR20220099963A
(ko)
|
2019-10-10 |
2022-07-14 |
예일 유니버시티 |
세포 수용체를 통한 분자 분해제로서의 조작된 항체
|
|
US20210189392A1
(en)
*
|
2019-12-12 |
2021-06-24 |
Aligos Therapeutics, Inc. |
S-antigen transport inhibiting oligonucleotide polymers and methods
|
|
US20230158155A1
(en)
|
2020-01-10 |
2023-05-25 |
Lycia Therapeutics, Inc. |
Cell Surface Receptor Binding Compounds and Conjugates
|
|
WO2021155317A1
(en)
|
2020-01-31 |
2021-08-05 |
Avilar Therapeutics, Inc. |
Asgpr-binding compounds for the degradation of extracellular proteins
|
|
WO2021156792A1
(en)
|
2020-02-07 |
2021-08-12 |
Novartis Ag |
Targeted plasma protein degradation
|
|
WO2021262693A1
(en)
|
2020-06-22 |
2021-12-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methotrexate analogs and methods of use
|
|
EP4171659A4
(en)
|
2020-06-24 |
2025-04-09 |
Lycia Therapeutics, Inc. |
BIFUNCTIONAL BRIDGE COMPOSITIONS FOR VIRAL TRANSDUCTION
|
|
EP4171658A4
(en)
|
2020-06-24 |
2025-04-09 |
Lycia Therapeutics, Inc. |
Modified viral compositions for viral transduction
|
|
CN113943288A
(zh)
|
2020-07-17 |
2022-01-18 |
微境生物医药科技(上海)有限公司 |
5,6-二氢吡嗪并[2,3-c]异喹啉化合物
|
|
WO2022035997A1
(en)
|
2020-08-11 |
2022-02-17 |
Avilar Therapeutics, Inc. |
In vivo assembly of asgpr binding therapeutics
|
|
EP4274619A4
(en)
|
2021-01-08 |
2025-09-24 |
Lycia Therapeutics Inc |
BIFUNCTIONAL FOLATE RECEPTOR-BINDING COMPOUNDS
|
|
EP4281115A1
(en)
|
2021-01-19 |
2023-11-29 |
Novartis AG |
Degradation of extracellular targets
|
|
AU2022222778A1
(en)
|
2021-02-22 |
2023-08-31 |
Yale University |
Targeted bifunctional degraders and methods using same
|
|
WO2022192478A1
(en)
|
2021-03-10 |
2022-09-15 |
Biohaven Therapeutics Ltd. |
Bifunctional degraders of galactose-deficient immunoglobulins
|
|
KR20240017423A
(ko)
|
2021-05-03 |
2024-02-07 |
아빌라 테라퓨틱스, 인크. |
이뮤노글로불린 및 다른 단백질의 분해를 위한 강력한 asgpr-결합 화합물
|
|
WO2022271981A2
(en)
|
2021-06-23 |
2022-12-29 |
Lycia Therapeutics, Inc. |
Bifunctional compounds containing igf-2 polypeptides
|
|
US20250127913A1
(en)
|
2021-06-24 |
2025-04-24 |
Lycia Therapeutics, Inc. |
Bifunctional folate receptor binding compounds
|
|
AU2022310346A1
(en)
|
2021-07-14 |
2024-01-25 |
Lycia Therapeutics, Inc. |
M6pr cell surface receptor binding compounds and conjugates
|
|
WO2023009554A1
(en)
|
2021-07-26 |
2023-02-02 |
Avilar Therapeutics, Inc. |
Methods to reduce adverse effects of gene or biologics therapy
|
|
WO2023028590A1
(en)
|
2021-08-27 |
2023-03-02 |
Yale University |
Molecular degraders of extracellular proteins
|
|
JP2024532362A
(ja)
|
2021-08-27 |
2024-09-05 |
イエール ユニバーシティ |
細胞外タンパク質の分子分解誘導剤
|
|
WO2023028338A2
(en)
|
2021-08-27 |
2023-03-02 |
Avilar Therapeutics, Inc. |
Mannose 6-phosphate or asgpr receptor binding compounds for the degradation of extracellular proteins
|
|
IL315579A
(en)
|
2022-03-15 |
2024-11-01 |
Univ Yale |
Small bifunctional compounds to target selective degradation of circulating proteins
|
|
EP4611818A2
(en)
|
2022-11-03 |
2025-09-10 |
Avilar Therapeutics, Inc. |
Asgpr-binding heterobifunctional compounds for the degradation of immunoglobulins
|